Sphingosine kinase 1 participates in insulin signalling and regulates glucose metabolism and homeostasis in KK/Ay diabetic mice

Diabetologia

Volumn 50, Issue 4, 2007, Pages 891-900

  Ma, M M ^a   Chen, J L ^b   Wang, G G ^b   Wang, H ^c   Lu, Y ^c   Li, J F ^b   Yi, J ^d   Yuan, Y J ^a   Zhang, Q W ^b   Mi, J ^b   Wang, L Sh ^b   Duan, H F ^b   Wu, C T ^b  

^a TIANJIN UNIVERSITY   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^d CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Glucose metabolism; Insulin signalling; Sphingosine kinase 1; Type 2 diabetes mellitus

Indexed keywords

ADENOVIRUS VECTOR; CHOLESTEROL; FATTY ACID; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3BETA; GREEN FLUORESCENT PROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; PROTEIN KINASE; PROTEIN KINASE B; SPHINGOSINE KINASE 1; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG SYNTHESIS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; GENE OVEREXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HEART INJURY; HEPATOMA CELL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IN VIVO STUDY; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIPID METABOLISM; LIVER; LIVER INJURY; METABOLIC REGULATION; MOUSE; MOUSE STRAIN; MYOTUBE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; CELL LINE, TUMOR; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; GENE TRANSFER TECHNIQUES; GLUCOSE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; INSULIN; MICE; MICE, TRANSGENIC; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 33847608656     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0589-5     Document Type: Article

References (48)

1. Choo HJ, Kim JH, Kwon OB et al (2006) Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia 49:784-791
2. Lin Y, Itani SI, Kurowski TG et al (2001) Inhibition of insulin signaling and glycogen synthesis by phorbol dibutyrate in rat skeletal muscle. Am J Physiol Endocrinol Metab 281:E8-E15
3. Dandona P, Aljada A, Bandyopadhyay A (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25:4-7
4. Hotamisligil GS (2003) Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord 27(Suppl 3):S53-S55
5. Boden G, She P, Mozzoli M et al (2005) Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-κB pathway in rat liver. Diabetes 54:3458-3465
6. Armstrong KA, Hiremagalur B, Haluska BA et al (2005) Free fatty acids are associated with obesity, insulin resistance, and atherosclerosis in renal transplant recipients. Transplantation 80:937-944
7. Brehm A, Krssak M, Schmid AI, Nowotny P, Waldhausl W, Roden M (2006) Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle. Diabetes 55:136-140
8. Summers SA (2006) Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 45:42-72
9. Summers SA, Nelson DH (2005) A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndrome. Diabetes 54:591-602
10. Dressler KA, Mathias S, Kolesnick RN (1992) Tumor necrosis factor-alpha activates the sphingomyelin signal transduction pathway in a cell-free system. Science 255:1715-1718
11. Summers SA, Garza LA, Zhou H, Birnbaum MJ (1998) Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Mol Cell Biol 18:5457-5464
12. Schmitz-Peiffer C, Craig DL, Biden TJ (1999) Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem 274:24202-24210
13. Chavez JA, Knotts TA, Wang LP et al (2003) A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 278:10297-10303
14. Teruel T, Hernandez R, Lorenzo M (2001) Ceramide mediates insulin resistance by tumor necrosis factor-alpha in brown adipocytes by maintaining Akt in an inactive dephosphorylated state. Diabetes 50:2563-2571
15. Shepherd PR, Withers DJ, Siddle K (1998) Phosphoinositide 3-kinase: the key switch mechanism in insulin signaling. Biochem J 333:471-490
16. Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296:1655-1657
17. Taniguchi CM, Emanuelli B, Kahn CR (2006) Critical nodes in signaling pathways: insights into insulin action. Nat Rev Mol Cell Biol 7:85-96
18. Hannun YA, Luberto C, Argraves KM (2001) Enzymes of sphingolipid metabolism: from modular to integrative signaling. Biochemistry 40:4893-4903
19. Merrill AH Jr, Schmelz EM, Dillehay DL et al (1997) Sphingolipids - the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol Appl Pharmacol 142:208-225
20. Maceyka M, Payne SG, Milstien S, Spiegel S (2002) Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim Biophys Acta 1585:193-201
21. Taha TA, Hannun YA, Obeid LM (2006) Sphingosine kinase: biochemical and cellular regulation and role in disease. J Biochem Mol Biol 39:113-131
22. Spiegel S, Kolesnick R (2002) Sphingosine 1-phosphate as a therapeutic agent. Leukemia 16:1596-1602
23. Obeid LM, Linardic CM, Karolak LA, Hannun YA (1993) Programmed cell death induced by ceramide. Science 259:1769-1771
24. Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind S, Spiegel S (1996) Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381:800-803
25. Verma NK, Singh J, Dey CS (2004) PPAR-gamma expression modulates insulin sensitivity in C2C12 skeletal muscle cells. Br J Pharmacol 143:1006-1013
26. Olivera A, Kohama T, Tu Z, Milstien S, Spiegel S (1998) Purification and characterization of rat kidney sphingosine kinase. J Biol Chem 273:12576-12583
27. Edsall LC, Spiegel S (1999) Enzymatic measurement of sphingosine 1-phosphate. Anal Biochem 272:80-86
28. Ancellin N, Colmont C, Su J et al (2002) Extracellular export of sphingosine kinase-1 enzyme. Sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation. J Biol Chem 277:6667-6675
29. Yahagi N, Shimano H, Hasty AH et al (2002) Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice. J Biol Chem 277:19353-19357
30. Liang Q, Carlson EC, Donthi RV, Kralik PM, Shen X, Epstein PN (2002) Overexpression of metallothionein reduces diabetic cardiomyopathy. Diabetes 51:174-181
31. Nakagawa Y, Shimano H, Yoshikawa T et al (2006) TFE3 transcriptionally activates hepatic IRS-2, participates in insulin signaling and ameliorates diabetes. Nat Med 12:107-113
32. Geoffroy K, Troncy L, Wiernsperger N, Lagarde M, El Bawab S (2005) Glomerular proliferation during early stages of diabetic nephropathy is associated with local increase of sphingosine-1-phosphate levels. FEBS Lett 579:1249-1254
33. Katsuma S, Hada Y, Ueda T et al (2002) Signaling mechanisms in sphingosine 1-phosphate-promoted mesangial cell proliferation. Genes Cells 7:1217-1230
34. Xu CB, Hansen-Schwartz J, Edvinsson L (2004) Sphingosine signaling and atherogenesis. Acta Pharmacol Sin 25:849-854
35. Jolly PS, Bektas M, Watterson KR et al (2005) Expression of SPHK1 impairs degranulation and motility of RBL-2H3 mast cells by desensitizing S1P receptors. Blood 105:4736-4742
36. Khan WA, Dobrowsky R, el Touny S, Hannun YA (1990) Protein kinase C and platelet inhibition by D-erythrosphingosine: comparison with N,N-dimethylsphingosine and commercial preparation. Biochem Biophys Res Commun 172:683-691
37. Young KW, Channing DR, Nahorski SR (2000) Effect of dimethylsphingosine on muscarinic M(3) receptor signaling in SH-SY5Y cells. Eur J Pharmacol 402:55-59
38. Wang LJ, Xing XP, Holmes A (2005) Activation of the sphingosine kinase-signaling pathway by high glucose mediates the proinflammatory phenotype of endothelial cells. Circ Res 97:891-899
39. Iwatsuka H, Shino A, Suzuoki Z (1970) General survey of diabetic features of yellow KK mice. Endocrinol Jpn 17:23-35
40. Maruhama Y, Ohneda A, Tadaki H et al (1975) Hepatic steatosis and the elevated plasma insulin level in patients with endogenous hypertriglyceridemia. Metabolism 24:653-664
41. Kruszynska YT, Olefsky JM (1996) Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus. J Investig Med 44:413-428
42. Seely BL, Olefsky JM (1993) Potential cellular and genetic mechanisms for insulin resistance in common disorders of obesity and diabetes. In: Moller D (ed) Insulin resistance and its clinical disorders. Wiley, Chichester, pp 187-252
43. DeFronzo RA, Ferrannini E (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194
44. Duan HF, Qu CK, Zhang QW et al (2006) Shp-2 tyrosine phosphatase is required for hepatocyte growth factor-induced activation of sphingosine kinase and migration in embryonic fibroblasts. Cell Signal 18:2049-2055
45. Zhang EE, Chapeau E, Hagihara K, Feng GS (2004) Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism. Proc Natl Acad Sci U S A 101:16064-16069
46. Penpargkul S, Schaible T, Yipintsoi T, Scheuer J (1980) The effect of diabetes on performance and metabolism of rat hearts. Circ Res 47:911-921
47. Massberg S, von Andrian UH (2006) Fingolimod and sphingosine-1-phosphate- modifiers of lymphocyte migration. N Engl J Med 355:1088-1091
48. Bolz SS, Vogel L, Sollinger D et al (2003) Sphingosine kinase modulates microvascular tone and myogenic responses through activation of RhoA/Rho kinase. Circulation 108:342-347